Date: 2016-01-04
Type of information: Services contract
Compound: database and state-of-the-art analysis tools
Company: Vertex Pharmaceuticals (USA-MA) Genomics (UK)
Therapeutic area: Technology - Services
Type agreement: services contract
Action mechanism:
Disease:
Details: * On January 4, 2016, Genomics, an analysis company developing algorithms, data resources, and software solutions to uncover the relationships between genetic variation and human disease, announced that Vertex Pharmaceuticals will use Genomics’ integrated database and state-of-the-art analysis tools to inform its drug research and development. These tools aim to provide confidence in the rationale for targeting Vertex’s pathways of interest for the treatment of certain diseases and to identify potential safety concerns and repositioning opportunities.
Genomics has developed a unique analytical platform for genome analysis and interpretation. The platform combines proprietary algorithms and software with the Company’s integrated genome-phenome database and analytical expertise to learn about human biology.
Financial terms:
Latest news:
